Company UpdateNewspaper Publication
Medical Equipment & Supplies
Shree Pacetronix Ltd
Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 45 filings·Updated 14 Aug 2026
Showing 10 of 45 filings.
14 Aug 20261 filing
13 Aug 20261 filing
ResultFinancial Results
Shree Pacetronix Q1 FY27: Standalone ₹489.67L revenue, PAT ₹76.31L; Consolidated PAT ₹75.59L; Limited Review.
Standalone results
- Standalone revenue from operations: ₹489.67 lakh in Q1 FY27.
- Standalone total revenue: ₹492.18 lakh in Q1 FY27.
- Standalone PAT: ₹76.31 lakh in Q1 FY27.
- Standalone basic EPS ₹2.04; diluted ₹1.96 (continuing ops).
- Audit Committee approved results; Limited Review report issued.
- Single operating segment: Life Saving Devices.
Consolidated results
- Consolidated revenue from operations: ₹489.67 lakh in Q1 FY27.
- Consolidated total revenue: ₹492.35 lakh in Q1 FY27.
- Consolidated PAT: ₹75.59 lakh in Q1 FY27.
- Consolidated basic EPS ₹2.02; diluted ₹1.94.
- Consolidated PBT: ₹101.25 lakh; tax ₹25.66 lakh.
- Results include Shree Coatomic Limited; limited review performed.
Audit & reporting
- Board approved results; Audit Committee reviewed on 13 Aug 2026.
- Company has only one segment: Life Saving Devices.
- Unaudited results; Limited Review conducted by auditors.
11 Aug 20261 filing
Company UpdateNewspaper Publication
In terms of Regulation 30 of the SEBI Listing Regulations, as amended and SEBI Circular dated January 30, 2026, please find enclosed herewith the newspaper advertisement pertaining to the ....
10 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dematerialisation processed; securities listed; certificates mutilated and owner updated within fifteen days
Dematerialisation status
- Securities received for dematerialisation during quarter ended 30 June 2026 were confirmed by us.
- Securities dematerialised have been listed on the stock exchanges where already listed.
- Physical certificates received were mutilated and cancelled; depository name updated as registered owner within fifteen days.
16 May 20261 filing
Board Meeting
Shree Pacetronix Ltd - 527005 - Board Meeting Intimation for Intimation Of BM (01St/2026-2027) Of The Com. Under Reg. 29(1) And (2) Of SEBI (LODR) Regulation 2015 To Inter-Alia, Consider And Approve The Standalone & Consolidated Audited FR For The Quarter And Financial Year Ended 31.03.2026
Meeting Details
- Board meeting scheduled for 25 May 2026 at 3:00 P.M.
- Location: registered office, Plot No. 15, Sector-II, Industrial Area, Pithampur, District Dhar, Madhya Pradesh.
Key Agenda Items
- Approve standalone and consolidated audited financial results for quarter and year ended 31 March 2026.
- Take on record statutory auditor's report on the audited standalone and consolidated results.
- Approve standalone and consolidated audited financial statements for year ended 31 March 2026.
Other Notes
- Trading window was already closed from 1 April 2026 until 48 hours after results announcement.
10 Apr 20261 filing
Company UpdateClarification
The Exchange has sought clarification from Shree Pacetronix Ltd on April 9, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
26 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, we wish to inform that the Trading Window for dealing in securities of the Company shall be closed for ....
24 Mar 20263 filings
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akash Sethi
Company UpdateGeneral
We have received intimation from Mr. Akash Sethi (Promoter & Managing Director) pursuant to Regulation 29(2) of the SEBI (SAST) Regulations regarding acquisition of 1,65,355 Equity Shares ....
Company UpdateGeneral
We have received intimation from Mr. Akash Sethi (Promoter & Managing Director) pursuant to Regulation 29(2) of the SEBI (SAST) Regulations regarding acquisition of 75,150 Equity Shares, ....
Showing 10 of 45 filings